The company has a market cap of Rs 122 crore and the stock gave multibagger returns of 884 per cent from its 52-week low of Rs 16.01 per share.

The is up by 40 per cent from its 52-week low of Rs 94.10 per share and gave multibagger returns of 465 per cent in 5 years

The company has a market cap of over Rs 50,000 crore and has been maintaining a healthy dividend payout of 35 per cent.

As of December 2024, the President of India owns a 61.75 per cent stake and the Life Insurance Corporation of India (LIC) owns a 5.11 per cent stake in the company.

Hotel Stock Trades 2 Per Cent Lower Despite Signing a New Property in Rajasthan

Two important concepts that help with this are the Value at Risk (VaR) Margin and Extreme Loss Margin (ELM).

The shares of the company have an ROE of 95 per cent and an ROCE of 117 per cent.

Regulatory changes, such as the US Biosecure Act, may accelerate growth for CDMO businesses. However, uncertainties remain, especially if Donald Trump returns to power. Trump has criticized India on trade issues, including pharmaceutical tariffs, which could impact domestic pharma strategies.

There are specific sessions, called Pre-Open Sessions and Special Pre-Open Sessions, that occur before the official market hours.

Small Finance Bank Shares in Focus After Approval to Sell Rs 364.51 Crore Micro Banking Loan Pool